Market Overview

Valeant Pharmaceuticals International, Inc. (NYSE: VRX)

24.27 -0.45 (-1.82%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2019
Pre-Market
EPS:
REV:
0.89
1.995B



Q4 2018
Pre-Market
EPS:
REV:
0.98
2.163B



Q3 2018
Pre-Market
EPS:
REV:
1.04
2.219B



Q2 2018
Pre-Market
EPS:
REV:
1.05
2.233B



Q1 2018
Pre-Market
EPS:
REV:
0.78
2.109B
0.6
1.95B
0.89
1.995B
48.33%
2.31%
Q4 2017
Pre-Market
EPS:
REV:
1.26
2.403B

0.98
2.163B

Q3 2017
Pre-Market
EPS:
REV:
1.55
2.48B

297.08M
1.04
2.219B

646.94%
Q2 2017
Pre-Market
EPS:
REV:
1.4
2.42B

1.05
2.233B

Q1 2017
Pre-Market
EPS:
REV:
1.55
2.76B

0.78
2.109B

Q4 2016
Pre-Market
EPS:
REV:

1.22
2.34B
1.26
2.403B
3.28%
2.69%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!